# Study of CD19/CD22 Chimeric Antigen Receptor T Cells in Children & Young Adults w/ Recurrent or Refractory B Cell Malignancies

> clinical trial · VERIFIED · 2026-06-30

Status: ACTIVE_NOT_RECRUITING · Sponsor: Stanford University · Condition: B Acute Lymphoblastic Leukemia

- Company: Stanford University
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT03241940

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.